Nan Wang

3.1k total citations · 1 hit paper
152 papers, 2.1k citations indexed

About

Nan Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nan Wang has authored 152 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 65 papers in Cancer Research and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nan Wang's work include Cancer-related molecular mechanisms research (37 papers), MicroRNA in disease regulation (34 papers) and Circular RNAs in diseases (29 papers). Nan Wang is often cited by papers focused on Cancer-related molecular mechanisms research (37 papers), MicroRNA in disease regulation (34 papers) and Circular RNAs in diseases (29 papers). Nan Wang collaborates with scholars based in China, United States and Japan. Nan Wang's co-authors include Zhe‐Sheng Chen, Zhiyong Ding, Ning Ji, Youyi Xiong, Yuanting Gu, Lin Li, Zubin Zhou, Guohui Yang, Zhuqing Zhang and Lina Liu and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Nan Wang

140 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proteomics technologies for cancer liquid biopsies

2022 149 citations Zhiyong Ding, Nan Wang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nan Wang China	26	1.1k	804	291	239	202	152	2.1k
Yifei Liu China	25	1.2k 1.1×	715 0.9×	403 1.4×	382 1.6×	118 0.6×	156	2.3k
Ping Han China	27	1.6k 1.5×	1.1k 1.3×	214 0.7×	196 0.8×	224 1.1×	122	2.7k
Weidong Jia China	28	1.1k 1.0×	691 0.9×	272 0.9×	463 1.9×	307 1.5×	131	2.3k
Jiahai Shi China	21	977 0.9×	479 0.6×	230 0.8×	159 0.7×	139 0.7×	91	1.7k
Lei Gao China	26	770 0.7×	414 0.5×	363 1.2×	294 1.2×	190 0.9×	110	1.8k
Weili Yang China	24	898 0.8×	422 0.5×	190 0.7×	226 0.9×	187 0.9×	110	2.1k
Long Wu China	25	842 0.8×	531 0.7×	188 0.6×	259 1.1×	156 0.8×	50	1.8k
Kai Qu China	25	963 0.9×	717 0.9×	254 0.9×	298 1.2×	260 1.3×	87	1.8k
Tao Tian China	26	1.0k 0.9×	645 0.8×	296 1.0×	499 2.1×	278 1.4×	107	2.0k

Countries citing papers authored by Nan Wang

Since Specialization

Citations

This map shows the geographic impact of Nan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Wang more than expected).

Fields of papers citing papers by Nan Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Wang. The network helps show where Nan Wang may publish in the future.

Co-authorship network of co-authors of Nan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Wang. A scholar is included among the top collaborators of Nan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Wang. Nan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Cheng, Zixiang Geng, Zhe Jiang, et al.. (2025). Discovery of Novel Selective Estrogen Receptor β (SERβ) Agonist ( S )-STO021 as an Antiosteoporosis Candidate with Dual Functions of Inhibiting Osteoclastogenesis and Activating Osteoblastogenesis. Journal of Medicinal Chemistry. 68(21). 22715–22737.

Wang, Nan, Mingjian Zhu, Jiahe Wu, et al.. (2025). Dual-targeting pluripotential biomimetic nanovehicle modulates tumor immune microenvironment for potentiated cancer chemoimmunotherapy. Chemical Engineering Journal. 523. 167894–167894.

Luo, Xinyu, et al.. (2024). Pharmacokinetics of trastuzumab and its efficacy and safety in HER2-positive cancer patients. Cancer Chemotherapy and Pharmacology. 94(5). 721–732. 1 indexed citations

Li, Xiangyü, et al.. (2024). Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study. Frontiers in Immunology. 14. 1327879–1327879. 11 indexed citations

Chen, Qiaoqiao, et al.. (2024). Extracellular vesicles (EVs)’ journey in recipient cells: from recognition to cargo release. Journal of Zhejiang University SCIENCE B. 25(8). 633–655. 9 indexed citations

Wang, Nan, et al.. (2023). ASO Author Reflections: Refining Radiotherapy Decisions in T3N0M0 Breast Cancer: A Nomogram-Based Approach. Annals of Surgical Oncology. 31(4). 2274–2275. 1 indexed citations

Li, Dawei, et al.. (2023). The identification and functional analysis of CircRNAs in endometrial receptivity of mice with polycystic ovary. Environmental Toxicology. 39(3). 1456–1470. 5 indexed citations

Xiong, Youyi, Lin Li, Nan Wang, et al.. (2023). Circ_0001387 regulates SKA2 to accelerate breast cancer progression through miR‐136‐5p. Thoracic Cancer. 14(18). 1707–1718. 4 indexed citations

Li, Zhichao, Feng Zhao, Gang Wang, et al.. (2023). Changes in the pulmonary function of CT-guided microwave ablation for patients with malignant lung tumors. Journal of Cancer Research and Therapeutics. 19(6). 1669–1674. 11 indexed citations

10.

Ren, Xueting, Nan Wang, Dandan Liu, et al.. (2022). Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer. Cancer Medicine. 11(20). 3886–3901. 16 indexed citations

11.

Zhang, Yingfan, Jiayi Li, Na Li, et al.. (2022). Loss of circSRY reduces γH2AX level in germ cells and impairs mouse spermatogenesis. Life Science Alliance. 6(2). e202201617–e202201617. 10 indexed citations

12.

Ding, Zhiyong, Nan Wang, Ning Ji, & Zhe‐Sheng Chen. (2022). Proteomics technologies for cancer liquid biopsies. Molecular Cancer. 21(1). 53–53. 149 indexed citations breakdown →

13.

Wang, Nan, Bingyan Li, Jun Zeng, et al.. (2022). Altered Expressions of Transfer RNA-Derived Small RNAs and microRNAs in the Vitreous Humor of Proliferative Diabetic Retinopathy. Frontiers in Endocrinology. 13. 913370–913370. 12 indexed citations

14.

Kong, Dezhong, Yu Xiong, Zhanbo Cheng, et al.. (2021). Stability analysis of coal face based on coal face-support-roof system in steeply inclined coal seam. Geomechanics and Engineering. 25(3). 233. 47 indexed citations

15.

Wu, Jian, Xuan Wang, Nan Wang, et al.. (2021). Identification of novel antioxidant gene signature to predict the prognosis of patients with gastric cancer. World Journal of Surgical Oncology. 19(1). 219–219. 16 indexed citations

16.

Chen, Zhuo, et al.. (2020). CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression. Cancer Cell International. 20(1). 400–400. 45 indexed citations

17.

Li, Lin, et al.. (2018). Relationship of Epidermal Growth Factor Receptor Expression with Clinical Symptoms and Metastasis of Invasive Breast Cancer. Journal of Interferon & Cytokine Research. 38(12). 578–582. 6 indexed citations

18.

Gao, Yong, et al.. (2016). Changes and mechanisms of Th9, Th17 and CD4+ CD25+ Foxp3+ regulatory T cells in the development of adult primary immune thrombocytopenia. Zhonghua weishengwuxue he mianyixue zazhi. 36(7). 500–505. 1 indexed citations

19.

Yan, Jun, Yanlin Yu, Nan Wang, et al.. (2004). LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma. Oncogene. 23(10). 1939–1949. 52 indexed citations

20.

Wang, Nan, et al.. (1999). Repair of acute descending aortic dissection complicated by visceral ischemia. The Annals of Thoracic Surgery. 68(3). 1067–1068. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact